Corporate Profile

Company Name Nichi-Iko Pharmaceutical Co., Ltd.
Head Quarters (Toyama) 1-6-21 Sogawa, Toyama City, Toyama Prefecture, Japan
Head Quarters (Tokyo) 5-4 Nihonbashi-Honcho 1-chome, Chuo-ku, Tokyo, Japan
Foundation July 15 1965
Capital 23,360 million yen
Affiliated Banks Hokuriku Bank, Sumitomo Mitsui Bank, Sumitomo Mitsui Trust Bank, MUFG Bank, Development Bank of Japan, Norinchukin Bank, Hokkoku Bank, Bank of Toyama
Fiscal Year March
Stock Exchange listings Tokyo Stock Exchange, First Section
Business Activities Manufacturing, sales, distribution, export, import and related activities for various types of pharmaceuticals;
Treatments for circulatory, digestive, respiratory, central and peripheral nervous systems and others; 1,229 items (as of December, 2020)
Employees 2,725 (as of March 31, 2021, consolidated)
R&D Sites Global Development Center [Toyama]
Production Sites 11 manufacturing plants
Hokkaido Plant (Antiseptics)
Yamagata Plant (External)
Saitama Plant (Oral Jelly, Eye Drop & Divided Liquid)
Shizuoka Plant (Tablets, Capsules, Granules & Injections)
Aichi Plant (Injections)
Gifu Plant (Tablets, Capsules & Injections)
Toyama Plant 1 (Tablets & Capsules)
Toyama Plant 2 (Powders & Granules)
Canada Omega Plant(Injections)
USA Raleigh Plant(Injections)
USA Plattsburgh Plant(Compound)
Distribution centers Nichi-Iko Distribution Center [Toyama]
East Japan Distribution Center [Saitama]
West Japan Distribution Center [Hyogo]
Hokkaido Distribution Center [Hokkaido]
Branch Offices Sapporo, Sendai, Kanto, Tokyo 1st & 2nd, Nagoya, Keiji-Hokuriku, Osaka, Hiroshima, Fukuoka
Overseas Subsidiaries Sagent Pharmaceuticals, Inc. [USA]
Omega Laboratories, Ltd. [Canada]
SterRx, LLC. [USA]
NIXS Corporation [USA]
Nichi-Iko(Thailand)Co., Ltd. [Thailand]
Subsidiaries
(Head Office Site)
Nichi-Iko Gifu Plant Co., Ltd. [Toyama]
Elmed Co., Ltd. [Toyama]
Yakuhan Pharmaceutical Co., Ltd. [Hokkaido]
EMI Inc. [Osaka]
Nichi-Iko Osaka Co., Ltd. [Osaka]